Rybelsus 3 mg contains Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist used for managing type 2 diabetes mellitus in adults. This oral medication works by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying, helping to lower blood sugar levels. The 3 mg dose is intended as a starting dose to initiate treatment and minimize gastrointestinal side effects before progressing to higher doses.

• Helps improve blood sugar control in adults with type 2 diabetes

• Initiates therapy with a well-tolerated, low dose

• Offers a convenient oral alternative to injectable GLP-1 receptor agonists

• Supports better patient adherence and comfort

• Lays the foundation for progression to more effective therapeutic doses (7 mg or 14 mg)

• Take one 3 mg tablet orally once daily

• Must be taken on an empty stomach, with up to 120 ml (4 oz) of plain water

• Wait at least 30 minutes before eating, drinking, or taking other medications

• Swallow the tablet whole without chewing or crushing

• 3 mg once daily for the first 30 days is the recommended starting dose

• After 30 days, treatment should be escalated to 7 mg once daily for continued glycemic control

• Not intended as a maintenance dose

• Any dosage change should be guided by a healthcare provider

• Not for use in type 1 diabetes or diabetic ketoacidosis

• Caution in patients with a history of pancreatitis, gastrointestinal disorders, or thyroid tumors

• Avoid co-use with other GLP-1 receptor agonists

• Not recommended during pregnancy or breastfeeding without medical advice

• Regular monitoring of blood sugar levels is advised

• Common side effects include:

• Nausea

• Vomiting

• Serious but rare side effects:

• Pancreatitis

• Kidney problems from dehydration

• Hypersensitivity reactions

• Possible risk of thyroid C-cell tumors (seen in animal studies)

•  

• Loss of appetite

• Diarrhea

• Indigestion

• Store below 30°C in a dry place

• Protect from moisture and heat

• Keep in original packaging

• Keep out of reach of children

Q1. What is Rybelsus 3 mg used for?
Rybelsus 3 mg is a starting dose to help the body adjust to Semaglutide and reduce gastrointestinal side effects before transitioning to higher doses.

Q2. Can I continue taking the 3 mg dose for long-term use?
No. It is not effective as a maintenance dose and should be followed by an increase to 7 mg after 30 days.

Q3. When should I take Rybelsus 3 mg?
Take it first thing in the morning on an empty stomach, with a small amount of water, and wait 30 minutes before consuming anything else.

Q4. Is it necessary to increase the dose after 30 days?
Yes. To achieve therapeutic effectiveness, the dose must be increased to 7 mg as directed by your healthcare provider.